https://www.selleckchem.com/pr....oducts/GSK429286A.ht
This study provides Class III evidence that a single dose of 72 IU intranasal oxytocin augments BOLD signal in patients with FTD during viewing of emotional facial expressions. To assess the frequency and determinants of depressive symptoms and suicidal thoughts in adults with narcolepsy type 1 (NT1) and controls, as well as the changes after NT1 management and the risk factors of major depressive episode (MDE) and suicide risk (SR) in NT1. Two hundred ninety-seven patients with NT1 (age 39 ± 17 years, 172 drug-free) and 346 controls
Like
Comment
Share
